Repetitive Thinking in Fibromyalgia

NCT03964285 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 47

Last updated 2025-09-19

No results posted yet for this study

Summary

Some fibromyalgia patients may use inappropriate emotional regulation strategies to respond to pain. Rumination could be one of this inefficient regulation strategies. The investigators believe that the use of rumination strategies to respond to the discomfort of daily physical activity would maintain and aggravate a negative emotional state after the effort. Distraction would be a more effective strategy to cope with pain. From this data, the investigators want to explore the causal link between rumination and negative affectivity after physical activity in fibromyalgia using an experimental design.

Conditions

  • Rumination
  • Fibromyalgia
  • Chronic Pain
  • Repetitive Negative Thinking

Interventions

OTHER

rumination induction

The induction method is based on specific instructions given to participants on how to focus on different elements of their experience. For example, they will be led, in the rumination condition, to reflect on the causes, meanings and consequences of the amount of tension they feel in their muscles.

OTHER

distraction induction

The induction method is based on specific instructions given to participants on how to focus on different elements of their experience. In the distraction condition they will, for example, imagine a ship crossing the Atlantic.

Sponsors & Collaborators

  • Université de Lille

    collaborator OTHER
  • Centre Hospitalier Universitaire, Amiens

    lead OTHER

Principal Investigators

  • Eric Serra, MD · CHU Amiens

  • Virginie Marechal, MD · CHU Amiens

  • Alain DERVAUX, MD · CHU Amiens

  • Jérémy Fonseca Das Neves, PhD · CHU Amiens

  • Stéphane Rusinek, PHD · Lille University

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-02-26
Primary Completion
2020-02-25
Completion
2020-02-25

Countries

  • France

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03964285 on ClinicalTrials.gov